19 May 2013
Keywords: zeneca, reveals, typically, strong, pipeline, december, pharmaceuticals
Article | 18 December 1995
On December 12, Zeneca Pharmaceuticals gave the first in-depth review of its research and development activities since the demerger with ICI ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.